[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @JoseRestonVA Jose Hurtado Jose Hurtado posts on X about $gald, novartis, $lonn, all the the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::4861119254/interactions)  - X Week XXXXXX -XX% - X Month XXXXXX +46% - X Months XXXXXXX +60% - X Year XXXXXXX +276% ### Mentions: XX [#](/creator/twitter::4861119254/posts_active)  - X Week XX no change - X Month XXX +17% - X Months XXX +48% - X Year XXX +186% ### Followers: XXXXX [#](/creator/twitter::4861119254/followers)  - X Week XXXXX +2.10% - X Month XXXXX +16% - X Months XXXXX +63% - X Year XXXXX +95% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::4861119254/influencer_rank)  ### Social Influence [#](/creator/twitter::4861119254/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [countries](/list/countries) XXXX% [finance](/list/finance) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$gald](/topic/$gald) #4, [novartis](/topic/novartis) #27, [$lonn](/topic/$lonn) #2, [all the](/topic/all-the) 2.99%, [$rna](/topic/$rna) 2.99%, [$ptgx](/topic/$ptgx) #23, [$nktr](/topic/$nktr) #18, [$sdz](/topic/$sdz) 1.49%, [$sdzny](/topic/$sdzny) 1.49%, [$lzagy](/topic/$lzagy) XXXX% **Top accounts mentioned or mentioned by** [@jfais20](/creator/undefined) [@andre_agtc](/creator/undefined) [@tradingsssss](/creator/undefined) [@seedy19tron](/creator/undefined) [@aafree](/creator/undefined) [@amaymd](/creator/undefined) [@sanctuarybio](/creator/undefined) [@maximusholla](/creator/undefined) [@monacobiotech](/creator/undefined) [@hothomaswphelps](/creator/undefined) [@oncinvestor](/creator/undefined) [@wallstsai](/creator/undefined) [@ltbioinvestor](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@flutestep](/creator/undefined) [@datadinvesting](/creator/undefined) [@rnaianalyst](/creator/undefined) [@mickeychiku](/creator/undefined) [@geneinvesting](/creator/undefined) [@longequity](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Ally Financial, Inc. (ALLY)](/topic/$ally) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Palantir (PLTR)](/topic/$pltr) [Oscar Health, Inc. (OSCR)](/topic/$oscr) [ROGin AI (ROG)](/topic/$rog) [Novo-Nordisk (NVO)](/topic/$nvo) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP)](/topic/$hznp) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) ### Top Social Posts [#](/creator/twitter::4861119254/posts) --- Top posts by engagements in the last XX hours "@WallStSai That would be a positive for Swiss pharma names. In addition to Roche and Novartis: Sandoz $SDZ ( $SDZNY in the US) Lonza $LONN ( $LZAGY in the US) Galderma $GALD (only Swiss ticker) there are others. Not sure about the impact on US names but it could help" [X Link](https://x.com/JoseRestonVA/status/1941198838754312491) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-07-04T18:14Z 2948 followers, 3531 engagements "Started a small position in Galderma $GALD here in the Swiss market (it does not trade in the US). Nemluvio launch in AD is strong and its portfolio of skin-care products showing solid growth. I will be adding to it from time to time as part of my Swiss-based portfolio" [X Link](https://x.com/JoseRestonVA/status/1962525131068063922) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-09-01T14:37Z 2948 followers, 1680 engagements "I have bought Galderma. ( $GALD in the Swiss market) recently. Regarding your comment about Nemluvio and its poor efficacy (I dont dispute) what is interesting is that the way this product is ramping up on sales in Q2 vs. Q1. This reinforces your assessment that there is a need for more solutions in the AD space and that even though Dupixent is the clear leader it does not solve by any means the demand. Otherwise Nemluvio wouldnt have the early performance it is showing. In my opinion this should bode well for eventually better products or different MOA" [X Link](https://x.com/JoseRestonVA/status/1964344283969806441) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-09-06T15:05Z 2948 followers, XXX engagements "Several of my small positions could be much larger down the road if the hypotheses for some of them play out but at this moment I need to see more data (certainly riskier). I already own X names in the AD space. In my Swiss portfolio I have Galderma $GALD. Enough for me. I do plan to reduce exposure to the US in the near term so I might trim some (will do my best to post - not that anybody cares)" [X Link](https://x.com/JoseRestonVA/status/1967841212062216315) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-09-16T06:41Z 2948 followers, XXX engagements "@jfais20 The interesting thing: if you look at $EPU (Peru ETF) on the daily for pretty much the entire year and only that you wouldnt tell the chaos in government. But if you look at $ARGT with all the bailouts etc it paints a different picture And there is a reason why" [X Link](https://x.com/JoseRestonVA/status/1976659771475558473) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-10T14:43Z 2941 followers, XXX engagements "@sharkbiotech I am actually more interested in (1) which other First Brands are out there and (2) $ALLY (JPM was increasing provision for consumer credit in Q3)" [X Link](https://x.com/JoseRestonVA/status/1978910263379157260) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-16T19:45Z 2940 followers, XXX engagements "@seedy19tron @A_May_MD I will take your comment assume positive intent and not sarcasm. No I am reducing exposure to the US" [X Link](https://x.com/JoseRestonVA/status/1979230787967791537) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-17T16:59Z 2940 followers, 1188 engagements "All good. Sorry for misunderstanding. Not the only names I am planning to exit. But at this moment I am reducing. No longer adding to either as they are both concentrated with different risk levels. I disagree on $MDGL as a short for now but I can change my mind depending on market share dynamics with NVO. The commentary on next quarter will help me assess direction. I am comfortable with $RNA but I want to see the MARINA-OLE data on DM1 (the main basis for my case). DMD is complementary for now and FSHD nice-to-have. Of the X one has certainly more upside (and risks) than the other. I am" [X Link](https://x.com/JoseRestonVA/status/1979232993710428671) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-17T17:08Z 2940 followers, 1448 engagements "I have more than my fair share of those Today I am getting a few worthless ones ( $PLTR $IMNM and $OSCR puts - all wrong hypothesis and / or execution) But those ones like yours when I sell something and then right after that a major moves happen.i lost hair after so much scratching :)" [X Link](https://x.com/JoseRestonVA/status/1979247126069612596) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-17T18:04Z 2941 followers, XXX engagements "@monaco_biotech In line with what I am seeing this morning with the trajectory of my Swiss names like Novartis $NOVN Roche $ROG Lonza $LONN . So far irrelevance" [X Link](https://x.com/JoseRestonVA/status/1971520523344752910) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-09-26T10:21Z 2947 followers, 2184 engagements "I agree. In biotech at least there is a disconnect between what chart-oriented traders think they see vs. reality. You explained well what is going on with $NVO - there are countless other cases as well. This is a sector where homework to understand what one really owns is required to attempt outsized returns in a consistent manner" [X Link](https://x.com/JoseRestonVA/status/1977436362765914368) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-12T18:09Z 2946 followers, 1066 engagements "@a_a_free I bought $PTGX with this dip" [X Link](https://x.com/JoseRestonVA/status/1977811427416273273) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-13T18:59Z 2947 followers, 1687 engagements "@doepke_michel Agreed. As I was in $BHVN as top position when it got acquired and then the new one near $X sometime later I can relate to it. No idea if this will be similar but I will not mind if it is. I am very late to $PTGX but I believe I can make it work" [X Link](https://x.com/JoseRestonVA/status/1977958434793271340) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-14T04:43Z 2947 followers, 1208 engagements "@monaco_biotech @seedy19tron He is entitled to short. Just a few weeks ago he said that $RNA was cooked" [X Link](https://x.com/JoseRestonVA/status/1978926548955582592) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-16T20:50Z 2947 followers, XXX engagements "@mickeychiku @A_May_MD nooo.ask me about $HZNP selling on a friday before getting bought outor ask me about selling INSM around $XX :) .and so many other instances" [X Link](https://x.com/JoseRestonVA/status/1979241218082005341) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-17T17:40Z 2946 followers, XXX engagements "@TheLordSwissLi1 @BowTiedBiotech Thanks for sharing. I am actually looking at Galderma ( missing John Bresnahan - he mentioned this name a while ago) $GALD - not sure if I will buy it but I am exploring it" [X Link](https://x.com/JoseRestonVA/status/1962235299766878690) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-08-31T19:25Z 2947 followers, XXX engagements "Whether or not this is a me too or have differentiated assets that become BIC will be determined via readouts next year. My hypothesis is that $APGE is the best of the challengers and therefore allocated funds that way compared to $NKTR $GALD (Galderma - clearly inferior but even they are growing) and $CRVS (there are others of course but those are the ones I am in)But yescertainly with risks. A buy-and-hold-and-manage name for me" [X Link](https://x.com/JoseRestonVA/status/1976212137719607560) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-09T09:04Z 2947 followers, XXX engagements "@nolastevedore You dont know Capital One. If you did you would not say that" [X Link](https://x.com/JoseRestonVA/status/1981030682978554062) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-22T16:11Z 2947 followers, XXX engagements "Exited $NKTR near $XX (fantastic) and $ORIC near $XXXX (decent profits). . @A_May_MD Thanks so much for sharing your brilliant analysis in Nektar. All the best to you here. Taking profits in some names as I will continue reducing exposure to the US from time to time" [X Link](https://x.com/JoseRestonVA/status/1979224536278094147) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-17T16:34Z 2947 followers, 7366 engagements "@galderma Nemluvio continues with a strong launch" [X Link](https://x.com/JoseRestonVA/status/1981257828158328929) [@JoseRestonVA](/creator/x/JoseRestonVA) 2025-10-23T07:14Z 2948 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@JoseRestonVA Jose Hurtado
Jose Hurtado posts on X about $gald, novartis, $lonn, all the the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX -XX%
- X Month XXXXXX +46%
- X Months XXXXXXX +60%
- X Year XXXXXXX +276%
Mentions: XX #
- X Week XX no change
- X Month XXX +17%
- X Months XXX +48%
- X Year XXX +186%
Followers: XXXXX #
- X Week XXXXX +2.10%
- X Month XXXXX +16%
- X Months XXXXX +63%
- X Year XXXXX +95%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX% countries XXXX% finance XXXX% cryptocurrencies XXXX%
Social topic influence $gald #4, novartis #27, $lonn #2, all the 2.99%, $rna 2.99%, $ptgx #23, $nktr #18, $sdz 1.49%, $sdzny 1.49%, $lzagy XXXX%
Top accounts mentioned or mentioned by @jfais20 @andre_agtc @tradingsssss @seedy19tron @aafree @amaymd @sanctuarybio @maximusholla @monacobiotech @hothomaswphelps @oncinvestor @wallstsai @ltbioinvestor @bowtiedbiotech @flutestep @datadinvesting @rnaianalyst @mickeychiku @geneinvesting @longequity
Top assets mentioned Novartis AG (NVS) Avidity Biosciences, Inc. Common Stock (RNA) Protagonist Therapeutics, Inc (PTGX) Ally Financial, Inc. (ALLY) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Palantir (PLTR) Oscar Health, Inc. (OSCR) ROGin AI (ROG) Novo-Nordisk (NVO) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) Apogee Therapeutics, Inc. Common Stock (APGE)
Top Social Posts #
Top posts by engagements in the last XX hours
"@WallStSai That would be a positive for Swiss pharma names. In addition to Roche and Novartis: Sandoz $SDZ ( $SDZNY in the US) Lonza $LONN ( $LZAGY in the US) Galderma $GALD (only Swiss ticker) there are others. Not sure about the impact on US names but it could help"
X Link @JoseRestonVA 2025-07-04T18:14Z 2948 followers, 3531 engagements
"Started a small position in Galderma $GALD here in the Swiss market (it does not trade in the US). Nemluvio launch in AD is strong and its portfolio of skin-care products showing solid growth. I will be adding to it from time to time as part of my Swiss-based portfolio"
X Link @JoseRestonVA 2025-09-01T14:37Z 2948 followers, 1680 engagements
"I have bought Galderma. ( $GALD in the Swiss market) recently. Regarding your comment about Nemluvio and its poor efficacy (I dont dispute) what is interesting is that the way this product is ramping up on sales in Q2 vs. Q1. This reinforces your assessment that there is a need for more solutions in the AD space and that even though Dupixent is the clear leader it does not solve by any means the demand. Otherwise Nemluvio wouldnt have the early performance it is showing. In my opinion this should bode well for eventually better products or different MOA"
X Link @JoseRestonVA 2025-09-06T15:05Z 2948 followers, XXX engagements
"Several of my small positions could be much larger down the road if the hypotheses for some of them play out but at this moment I need to see more data (certainly riskier). I already own X names in the AD space. In my Swiss portfolio I have Galderma $GALD. Enough for me. I do plan to reduce exposure to the US in the near term so I might trim some (will do my best to post - not that anybody cares)"
X Link @JoseRestonVA 2025-09-16T06:41Z 2948 followers, XXX engagements
"@jfais20 The interesting thing: if you look at $EPU (Peru ETF) on the daily for pretty much the entire year and only that you wouldnt tell the chaos in government. But if you look at $ARGT with all the bailouts etc it paints a different picture And there is a reason why"
X Link @JoseRestonVA 2025-10-10T14:43Z 2941 followers, XXX engagements
"@sharkbiotech I am actually more interested in (1) which other First Brands are out there and (2) $ALLY (JPM was increasing provision for consumer credit in Q3)"
X Link @JoseRestonVA 2025-10-16T19:45Z 2940 followers, XXX engagements
"@seedy19tron @A_May_MD I will take your comment assume positive intent and not sarcasm. No I am reducing exposure to the US"
X Link @JoseRestonVA 2025-10-17T16:59Z 2940 followers, 1188 engagements
"All good. Sorry for misunderstanding. Not the only names I am planning to exit. But at this moment I am reducing. No longer adding to either as they are both concentrated with different risk levels. I disagree on $MDGL as a short for now but I can change my mind depending on market share dynamics with NVO. The commentary on next quarter will help me assess direction. I am comfortable with $RNA but I want to see the MARINA-OLE data on DM1 (the main basis for my case). DMD is complementary for now and FSHD nice-to-have. Of the X one has certainly more upside (and risks) than the other. I am"
X Link @JoseRestonVA 2025-10-17T17:08Z 2940 followers, 1448 engagements
"I have more than my fair share of those Today I am getting a few worthless ones ( $PLTR $IMNM and $OSCR puts - all wrong hypothesis and / or execution) But those ones like yours when I sell something and then right after that a major moves happen.i lost hair after so much scratching :)"
X Link @JoseRestonVA 2025-10-17T18:04Z 2941 followers, XXX engagements
"@monaco_biotech In line with what I am seeing this morning with the trajectory of my Swiss names like Novartis $NOVN Roche $ROG Lonza $LONN . So far irrelevance"
X Link @JoseRestonVA 2025-09-26T10:21Z 2947 followers, 2184 engagements
"I agree. In biotech at least there is a disconnect between what chart-oriented traders think they see vs. reality. You explained well what is going on with $NVO - there are countless other cases as well. This is a sector where homework to understand what one really owns is required to attempt outsized returns in a consistent manner"
X Link @JoseRestonVA 2025-10-12T18:09Z 2946 followers, 1066 engagements
"@a_a_free I bought $PTGX with this dip"
X Link @JoseRestonVA 2025-10-13T18:59Z 2947 followers, 1687 engagements
"@doepke_michel Agreed. As I was in $BHVN as top position when it got acquired and then the new one near $X sometime later I can relate to it. No idea if this will be similar but I will not mind if it is. I am very late to $PTGX but I believe I can make it work"
X Link @JoseRestonVA 2025-10-14T04:43Z 2947 followers, 1208 engagements
"@monaco_biotech @seedy19tron He is entitled to short. Just a few weeks ago he said that $RNA was cooked"
X Link @JoseRestonVA 2025-10-16T20:50Z 2947 followers, XXX engagements
"@mickeychiku @A_May_MD nooo.ask me about $HZNP selling on a friday before getting bought outor ask me about selling INSM around $XX :) .and so many other instances"
X Link @JoseRestonVA 2025-10-17T17:40Z 2946 followers, XXX engagements
"@TheLordSwissLi1 @BowTiedBiotech Thanks for sharing. I am actually looking at Galderma ( missing John Bresnahan - he mentioned this name a while ago) $GALD - not sure if I will buy it but I am exploring it"
X Link @JoseRestonVA 2025-08-31T19:25Z 2947 followers, XXX engagements
"Whether or not this is a me too or have differentiated assets that become BIC will be determined via readouts next year. My hypothesis is that $APGE is the best of the challengers and therefore allocated funds that way compared to $NKTR $GALD (Galderma - clearly inferior but even they are growing) and $CRVS (there are others of course but those are the ones I am in)But yescertainly with risks. A buy-and-hold-and-manage name for me"
X Link @JoseRestonVA 2025-10-09T09:04Z 2947 followers, XXX engagements
"@nolastevedore You dont know Capital One. If you did you would not say that"
X Link @JoseRestonVA 2025-10-22T16:11Z 2947 followers, XXX engagements
"Exited $NKTR near $XX (fantastic) and $ORIC near $XXXX (decent profits). . @A_May_MD Thanks so much for sharing your brilliant analysis in Nektar. All the best to you here. Taking profits in some names as I will continue reducing exposure to the US from time to time"
X Link @JoseRestonVA 2025-10-17T16:34Z 2947 followers, 7366 engagements
"@galderma Nemluvio continues with a strong launch"
X Link @JoseRestonVA 2025-10-23T07:14Z 2948 followers, XXX engagements